Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Record History now shows a new revision label, Revision: v3.5.3, replacing Revision: v3.5.2. This update represents a small page version update rather than changes to the trial content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe record history now includes a new revision entry v3.5.2 and removes v3.5.0 from the list.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded a new 'Study Status' entry on 2026-03-25 and version 9 on 2026-03-23. Deleted the 2025-05-29 entry.SummaryDifference0.4%

- Check52 days agoChange DetectedAdded revision: v3.5.0; removed revision: v3.4.3 from the record history.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the Record History.SummaryDifference0.1%

- Check88 days agoChange DetectedAdded revision entry v3.4.2 and removed v3.4.1 from the Record History page, updating the displayed site version history.SummaryDifference0.1%

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.